Spinal chordoma is a rare, slow-growing cancer that starts in the bones of the spine. It usually affects adults, especially in midlife or later, and it can cause pain, numbness, weakness, or bowel and bladder problems as it presses on nearby nerves. Many people only realize later that their symptoms were connected to spinal chordoma, and early symptoms of spinal chordoma can be easy to mistake for common back problems. Spinal chordoma often lasts for years and can come back after treatment, so long-term follow-up is important. Treatment usually involves surgery and often radiation therapy, and the outlook varies based on the tumor’s size, location, and whether it can be fully removed.
How many people live with Spinal chordoma?
There is no single authoritative count of how many people are living with spinal chordoma worldwide or in the United States. Chordoma overall affects about 1 person per million worldwide each year and about 300 people in the United States each year (Chordoma Foundation, 2024). Because about 60% to 70% of chordomas start in the spine, spinal chordoma is estimated to account for roughly 4,900 to 5,700 new cases worldwide and about 180 to 210 new U.S. cases each year, but these are estimates of new diagnoses, not direct counts of everyone living with the disease.
Overview
Spinal chordomaSymptoms
Spinal chordoma often causes deep back or neck pain that does not go away. Some people also notice numbness, weakness, or tingling if the tumor presses on nearby nerves. Early symptoms of spinal chordoma can be easy to mistake for common back problems.
Outlook and prognosis
Spinal chordoma often grows slowly, but it can come back after treatment and may press on the spinal cord or nearby nerves over time. Outlook depends a lot on complete removal and location. Many live for years with careful follow-up.
Causes and risk factors
Spinal chordoma usually starts from leftover cells from early fetal development. Most cases happen by chance, but rare inherited changes, including extra copies of the brachyury gene, can raise risk. It is more common in older adults and in males.
Genetic influences
Spinal chordoma is usually not inherited. Most cases arise from gene changes that happen during life, especially extra copies or activity of the brachyury gene; rarely, inherited TBXT changes can raise spinal chordoma risk in families.
Diagnosis
Spinal chordoma is usually diagnosed with imaging, often MRI and CT, followed by a biopsy to confirm the tumor type. Diagnosis also considers symptoms, exam findings, and where the growth sits along the spine.
Treatment and drugs
Treatment for spinal chordoma often centers on surgery to remove as much tumor as safely possible, followed by focused radiation. If it comes back or has spread, some people may be offered medicines or a clinical trial.
Symptoms
Spinal chordoma often causes symptoms slowly, so it may feel like a back or neck problem that never fully settles. The changes are often subtle at first, blending into daily life until they become more noticeable. Pain is usually the first sign, but symptoms depend on where the tumor is and whether it presses on nearby nerves or the spinal cord. The early symptoms of spinal chordoma can be easy to mistake for more common causes of back pain.
Ongoing pain in the back or neck is the most common symptom. It is often deep, aching, and persistent rather than coming and going like a pulled muscle. For many, it may be worse at night or when lying down.
Pain can travel from the spine into the shoulder, chest, arm, buttock, or leg if nearby nerves are irritated. Some people describe it as sharp, burning, or shooting rather than a simple backache.
Pressure on nerves can cause pins and needles, reduced feeling, or an odd heavy sensation in an arm, leg, or around the pelvis. You might notice small changes at first, such as a foot that feels less responsive or fingers that seem unusually clumsy.
If spinal chordoma affects the spinal cord or nerve roots, muscles may become weak. This can show up as trouble climbing stairs, lifting the front of the foot, gripping objects, or walking steadily.
How people usually first notice Spinal chordoma?
Spinal chordoma often enters the story quietly, with pain that does not behave like a simple strain: many people first notice a deep, steady ache in the neck, back, or tailbone area that slowly gets worse over weeks or months and may be worse at night. As the tumor grows, it can press on nearby nerves or the spinal cord, so the first signs of spinal chordoma may also include tingling, numbness, weakness in an arm or leg, trouble walking, or changes with bladder or bowel control, depending on where in the spine it starts. Because these symptoms can look like much more common back problems, spinal chordoma is often first noticed only when the pain persists, keeps progressing, or starts to come with nerve-related symptoms.
Types of Spinal chordoma
Spinal chordoma can behave differently depending on the tumor subtype, and that can affect how fast it grows and what symptoms show up first. In practice, the main types of spinal chordoma are defined by how the tumor cells look under the microscope, and these differences can shape both severity and pace. Symptoms do not always look the same for everyone, but pain, nerve pressure, weakness, or bowel and bladder changes are often the day-to-day issues people notice. When doctors talk about the types of spinal chordoma, they usually mean these recognized clinical variants.
Conventional chordoma
This is the most common type of spinal chordoma and it often grows slowly over time. Many living with it first notice deep back or neck pain, then numbness, weakness, or tingling if the tumor presses on nearby nerves or the spinal cord. Symptoms may build gradually, so it can be mistaken for more common spine problems at first.
Chondroid chordoma
This subtype shares features of both chordoma and cartilage-forming tumors, and it may behave somewhat less aggressively than conventional chordoma in some people. Symptoms are usually similar, such as ongoing spinal pain, stiffness, or nerve-related changes, but the course can be a little slower. Not everyone will experience every type of symptom.
Dedifferentiated chordoma
This is a rarer and more aggressive form that tends to grow faster and spread more easily than other variants of spinal chordoma. People with this type may develop worsening pain over a shorter time, along with faster changes in strength, walking, or bladder and bowel control. Because it can progress quickly, symptoms often feel more abrupt and severe.
Poorly differentiated
This uncommon subtype is seen more often in children and younger adults than in older adults. It can act aggressively, and symptoms may include rapidly increasing pain, weakness, sensory loss, or trouble with movement depending on where in the spine the tumor sits. Early symptoms of spinal chordoma in this form may be subtle at first but tend to worsen more quickly than in conventional disease.
Can I slow down the onset of symptoms?
No, at this time there is no good evidence that lifestyle changes or medicines can meaningfully delay the start of symptoms or prevent spinal chordoma. Healthy habits such as regular activity, not smoking, good sleep, and a balanced diet are still important for overall health, but they have not been shown to lower the risk of spinal chordoma or stop it from starting. There are also no proven screening tests or preventive drugs for most people, so if you have ongoing back pain, weakness, numbness, or bladder or bowel changes, getting checked early may help doctors find the cause sooner, even though it does not delay when the condition begins.
What genetics can tell you about symptoms
In spinal chordoma, genetics can sometimes help explain risk, but they usually do not tell exactly which symptoms someone will have day to day. Rare inherited changes, especially involving a gene linked to notochord development, can raise the chance of developing chordoma, and some tumor gene changes may be tied to how the cancer behaves, but symptoms are still driven mostly by where the tumor is in the spine, how large it is, and whether it is pressing on nerves or the spinal cord. In other words, genetics may offer clues about why chordoma developed and, in some cases, how aggressive it may be, but they are not a reliable way to predict the exact symptoms, their severity, or when they will begin.
Causes and risk factors
Spinal chordoma usually starts from a small group of leftover cells near the spine that were present before birth. Over time, DNA changes in these cells can make them grow out of control, but the exact trigger is often unknown. Researchers are still learning how these pieces fit together. Known risk factors for spinal chordoma include older age, being male, and in rare families, inherited gene changes. So far, doctors have not found clear links between spinal chordoma and smoking, diet, exercise, or most environmental exposures.
What are the most common causes or risk factors?
Spinal chordoma starts from tiny leftover cells near the spine that were present before birth, but in most people, doctors do not know why these cells later turn into cancer. The clearest risk factors are rare inherited gene changes that can run in families, and it is also seen more often in adults, especially older adults, and slightly more often in men. There are no well-proven links to common lifestyle habits or everyday environmental exposures.
Environmental and biological risk factors
Spinal chordoma is a rare tumor, and its risk factors are not as well defined as they are for many other cancers. Most people who develop spinal chordoma have no clear outside cause. Doctors often group risks into internal (biological) and external (environmental), but for spinal chordoma, only a few biological patterns are well established and environmental links remain uncertain.
Spinal chordoma is most often diagnosed in adults, especially between about ages 40 and 70. It can happen earlier or later, but it is much less common in children and younger adults.
Spinal chordoma is seen more often in males than in females. This does not mean females are protected, only that the overall risk appears somewhat higher in males.
Spinal chordoma begins in leftover cells from the notochord, a temporary structure present very early in development. These cell remnants can stay in the spine for life, but only rarely do they grow into a tumor.
No home, workplace, or environmental exposure has been clearly proven to cause spinal chordoma. In most cases, doctors cannot identify a specific outside trigger.
Genetic risk factors
Spinal chordoma usually happens by chance, and most people with it do not inherit a changed gene from a parent. The main inherited link found so far involves the TBXT gene, which helps form early tissues along the future spine before birth. Carrying a genetic change doesn’t guarantee the condition will appear. When doctors talk about the genetic risk factors for spinal chordoma, they are usually referring to rare family patterns or DNA changes that arise only in the tumor itself.
Sporadic cases: Most spinal chordoma cases are sporadic, meaning they are not passed down through a family. In these cases, gene changes develop in the tumor cells themselves and are not usually present in the rest of the body.
TBXT duplication: In a small number of families, an extra copy of the TBXT gene can greatly increase the chance of chordoma. This gene is important in early development of the notochord, the tissue spinal chordoma is thought to grow from.
Family history: Having a close relative with chordoma can raise risk, but this inherited pattern is very rare. If several family members have had chordoma, genetic counseling and sometimes testing may help show whether an inherited gene change is involved.
SMARCB1 changes: Rarely, chordoma is linked to inherited changes in a gene called SMARCB1, especially in children and in less common tumor types. This is not the usual cause of spinal chordoma in adults, but it can matter when the tumor appears at a young age or runs in a family.
Lifestyle risk factors
Spinal chordoma is not known to be caused by lifestyle habits, and there are no well-established lifestyle risk factors for spinal chordoma in the way there are for many common cancers. Still, how lifestyle affects spinal chordoma can matter for symptoms, treatment tolerance, recovery, and complications. The main effects are indirect, influencing overall health, wound healing, mobility, pain, and rehabilitation rather than triggering the tumor itself.
Smoking is not a proven cause of spinal chordoma, but it can reduce blood flow and impair wound healing after surgery. It may also worsen lung function, which can make anesthesia, recovery, and radiation-related fatigue harder to manage.
Low activity does not appear to cause spinal chordoma, but prolonged inactivity can worsen muscle loss, stiffness, balance problems, and functional decline. Safe, guided movement may help preserve mobility and support rehabilitation during or after treatment.
Poor nutrition does not seem to increase the chance of developing spinal chordoma, but it can slow healing and contribute to weakness and weight loss during treatment. Adequate protein, calories, and overall nutrient intake may support recovery and help maintain strength.
Heavy alcohol use is not an established cause of spinal chordoma, but it can interfere with sleep, pain control, nutrition, and recovery. It may also increase fall risk and make it harder to stay engaged in rehabilitation.
Risk prevention
For most people, spinal chordoma cannot be prevented because it usually happens without a clear, avoidable cause. This rare tumor is not linked to the usual lifestyle risks that matter for many other cancers. In a small number of families, inherited risk may play a role, so prevention is mainly about recognizing higher-risk situations and reducing the chance of delayed diagnosis. Prevention is about lowering risk, not eliminating it completely.
There is no known diet, exercise plan, or routine habit that has been shown to prevent spinal chordoma. Many people living with spinal chordoma did nothing to cause it.
A very small number of people have an inherited tendency that can raise the chance of chordoma. If close relatives have had chordoma, genetic counseling can help clarify risk and whether specialist follow-up makes sense.
You cannot prevent spinal chordoma by spotting it early, but early evaluation may reduce complications from a growing tumor. Ongoing back or neck pain, weakness, numbness, or changes in bladder or bowel control should be checked, especially if early symptoms of spinal chordoma do not go away.
People with a known inherited risk may be advised to have care through a center familiar with chordoma. Different people need different prevention strategies—there’s no single formula.
Can you prevent Spinal chordoma?
No, there is no known way to prevent spinal chordoma. It is not linked to clear lifestyle factors like diet, exercise, or smoking, and most cases seem to happen by chance. In a small number of families there may be an inherited risk, but even then there is no proven way to stop it from developing.
Transmission
Spinal chordoma is not infectious, so it cannot be passed from one person to another through touch, kissing, sex, blood, coughing, or sharing food. For many living with spinal chordoma, this means there is no risk of family members or close contacts "catching" the tumor.
Most cases happen sporadically, meaning they develop by chance rather than being passed down in a family. When people ask how spinal chordoma is inherited, the answer is that inherited cases are rare, although a small number of families have a higher risk because of an inherited gene change.
When to test your genes
For spinal chordoma, genetic testing is usually most useful if you have chordoma at a young age, more than one affected relative, or multiple chordomas in the family, because rare inherited changes such as TBXT duplication can run in families. If you already have chordoma, tumor genetic testing may help guide clinical trial options and personalize care.
Diagnosis
Spinal chordoma is often diagnosed after ongoing back or neck pain, weakness, numbness, or bowel and bladder changes lead to medical evaluation. Because these tumors grow slowly, the early symptoms of spinal chordoma can look like more common spine problems at first. It’s natural to worry when symptoms don’t have a clear explanation. The diagnosis of spinal chordoma usually comes from scans of the spine followed by a biopsy to confirm the tumor type.
Doctors ask about pain, numbness, weakness, balance problems, and any changes in bladder or bowel control. They also look at how symptoms have changed over time and whether they suggest pressure on the spinal cord or nearby nerves.
A physical exam checks strength, reflexes, sensation, and walking. These findings can show which part of the spine may be affected and how much the tumor is interfering with nerve function.
MRI is usually the main imaging test for spinal chordoma because it shows the tumor and nearby spinal cord, nerves, and soft tissues in detail. It helps doctors see the size of the mass and whether it has grown into surrounding structures.
CT scans give a clearer view of bone and can show how spinal chordoma is affecting the vertebrae. This can help with diagnosis and with planning the safest approach for biopsy or surgery.
How is Spinal chordoma diagnosed?
Spinal chordoma is usually diagnosed after a doctor reviews symptoms, does an exam, and orders spine scans, most often an MRI and often a CT scan, to see the size of the growth and whether it is affecting nearby bone, nerves, or the spinal cord. The diagnosis is then confirmed by taking a small sample of the growth, often with a needle or during surgery, and checking it under a microscope. Genetic testing is not usually the main way this cancer is diagnosed, but special lab tests on the tumor, and sometimes gene testing, can help confirm the diagnosis and guide treatment.
Stages of Spinal chordoma
Spinal chordoma does not have defined progression stages. That is because it is usually described by where it starts, how large it is, and whether it has grown into nearby tissues or spread, rather than by a step-by-step pattern over time. Often the process begins when you notice changes in daily life, such as ongoing back pain, nerve pain, weakness, or bowel or bladder problems, which can overlap with early symptoms of spinal chordoma. Doctors usually diagnose and monitor spinal chordoma with imaging such as MRI and CT scans, and a biopsy is usually needed to confirm the diagnosis.
Outlook and prognosis
The outlook for spinal chordoma is variable and depends largely on whether the tumor can be completely removed, its size and location, and whether it has already spread or come back after treatment. Even though it usually grows slowly, spinal chordoma is locally aggressive and has a high risk of recurrence, sometimes many years after initial therapy, so long-term follow-up is essential. Prognosis is generally better when surgery achieves wide, en bloc removal with clear margins, often combined with high-dose radiation, while tumors that cannot be fully resected tend to have worse outcomes. Metastases can occur, most often to the lungs, bone, liver, or lymph nodes, and their presence is associated with reduced survival. Reported 5-year survival rates are often around 50% to 70%, but long-term survival drops over time because of repeated local recurrence and late metastatic disease. Mortality is usually related to progressive local tumor growth affecting the spinal cord or nearby vital structures, treatment complications, or metastatic spread.
Long-term effects
Spinal chordoma can have lasting effects because it often grows close to the spinal cord, nerves, and other important structures. Even after treatment, some people live with ongoing pain, weakness, or changes in daily function. The long-term picture is often shaped by where the tumor started, whether it comes back, and how much nearby tissue was affected. For many, the long-term effects of spinal chordoma are linked both to the tumor itself and to treatment over time.
Ongoing back or neck pain can continue long after treatment, especially if nerves, bones, or soft tissues were affected. Many living with spinal chordoma describe pain that flares with sitting, walking, or turning in bed.
Pressure on the spinal cord or nearby nerves can lead to lasting weakness, numbness, tingling, or balance problems. Some may find that climbing stairs, using their hands, or walking longer distances becomes harder than before.
If lower spinal nerves are involved, long-term effects can include trouble controlling the bladder or bowels, or difficulty fully emptying them. Sexual function may also be affected in some people, depending on the tumor location and treatment area.
Surgery and radiation can leave lasting stiffness, reduced flexibility, or changes in posture and spinal stability. For many, this can mean daily routines may take longer, such as getting dressed, driving, or standing for extended periods.
How is it to live with Spinal chordoma?
Living with spinal chordoma often means coping with a tumor that grows slowly but can press on the spine, nerves, or nearby tissues, so daily life may be shaped by persistent pain, stiffness, weakness, numbness, fatigue, or limits on sitting, walking, lifting, and sleep. Many people living with spinal chordoma also face long stretches of treatment and recovery, with repeated scans, surgery, radiation, rehabilitation, and the emotional strain of uncertainty because the tumor can return even after treatment. For partners, family, and close friends, this can mean stepping into caregiving roles, helping with transportation, mobility, appointments, and household tasks, while also carrying their own worry and adjustment.
Treatment and drugs
Spinal chordoma is usually treated with a mix of surgery and radiation, with the main goal being to remove or control the tumor while protecting the spinal cord and nearby nerves. When it is possible, surgeons try to take out the whole tumor in one piece, because this gives the best chance of keeping spinal chordoma from coming back. Treatment plans often combine several approaches. Radiation is often used after surgery, or sometimes instead of surgery when the tumor is in a hard-to-reach area, and highly focused types such as proton therapy may help limit damage to nearby tissue. If spinal chordoma has spread, comes back, or cannot be fully removed, some people may be offered drug treatment, clinical trials, pain relief, and physical rehabilitation to help with movement and day-to-day function.
Can you cure Spinal chordoma?
Sometimes, yes, but not always: spinal chordoma has the best chance of being cured when the whole tumor can be safely removed and often treated with radiation too. Because these tumors grow close to the spinal cord, nerves, and other important tissues, complete removal is not always possible, and the tumor can come back even after treatment. When a cure is not possible, treatment can still help by slowing growth, easing pain and nerve problems, and helping people live longer.
Non-drug treatment
Spinal chordoma often affects everyday movement, comfort, and independence, so treatment usually focuses on controlling the tumor while protecting nerve function as much as possible. Managing this condition often means care from a team that may include spine surgeons, radiation specialists, rehabilitation clinicians, and pain experts. Because spinal chordoma grows close to the spinal cord and major nerves, treatment plans are highly individualized. For many living with spinal chordoma, the best results come from combining local tumor treatment with rehabilitation and supportive care.
Surgery is often the main non-drug treatment for spinal chordoma, especially when doctors believe most or all of the tumor can be removed. The goal is to take out the tumor as completely as possible while preserving spinal stability and nerve function.
High-dose radiation is commonly used for spinal chordoma, either after surgery or sometimes when surgery is not possible. Advanced methods such as proton therapy or highly focused radiation can help target the tumor while limiting damage to nearby spinal cord tissue.
Physical therapy and rehabilitation can help with walking, strength, balance, and safe movement after treatment. Some may find that structured rehab is especially helpful during recovery from spinal chordoma surgery, when stiffness, weakness, or fatigue can make daily tasks harder.
Occupational therapy focuses on practical skills like dressing, bathing, getting in and out of bed, and returning to work or hobbies. Therapists may also suggest safer ways to move and protect your spine during recovery.
Your genes may have an impact on how drugs work for you
For people living with spinal chordoma, genetics can sometimes affect treatment in two different ways: inherited differences may change how the body breaks down medicines such as pain relievers, while changes in the tumor itself may affect how well certain cancer drugs work. In day-to-day life, this can mean one person gets good pain relief or fewer side effects, while another may need a different dose or a different medicine altogether. Even so, gene-based drug matching is not yet a routine part of care for most spinal chordoma treatments, and doctors more often base medication choices on symptoms, side effects, and how the tumor responds over time.
Pharmacological treatments
Drug treatment for spinal chordoma is usually considered when the tumor cannot be fully removed, comes back, or has spread. Standard chemotherapy often does not work well for chordoma, so doctors more often use targeted drugs, immunotherapy in selected cases, and medicines to control symptoms. Not everyone responds to the same medication in the same way. In many cases, treatment is individualized and may include a clinical trial.
Imatinib is one of the best-known targeted drugs used for advanced spinal chordoma, especially when the tumor shows activity in a growth pathway called PDGFR. It may help slow tumor growth or ease symptoms, but it usually does not make the tumor disappear.
Erlotinib and afatinib are targeted drugs sometimes used when spinal chordoma has changes involving EGFR, a signal that can help cancer cells grow. These medicines are not right for everyone, but some people have meaningful tumor control with them.
Sirolimus or everolimus may be used in some cases, sometimes together with another targeted drug such as imatinib. If one option is not effective, second-line or alternative drugs may be offered, especially at centers with chordoma experience.
Pazopanib, sunitinib, and sorafenib are examples of multitargeted cancer drugs that may be considered for recurrent or metastatic chordoma. Evidence is still limited, but they can sometimes slow progression when other options have not helped enough.
Genetic influences
Most spinal chordoma cases happen by chance and are not inherited from a parent. Still, genetics can matter, especially in the rare families where several relatives develop chordoma; a gene called TBXT, which helps shape the spine very early in development, is the best-known inherited cause, which is why some families ask whether spinal chordoma runs in families. Family history is one of the strongest clues to a genetic influence.
Doctors can also find gene changes inside the spinal chordoma tumor itself that arose only in the cancer cells and were not present at birth. For many living with spinal chordoma, this means genetic testing is not routine for everyone, but it may be worth discussing if more than one close relative has had chordoma or if it appears at a younger age than expected.
Is Spinal chordoma genetic?
Spinal chordoma is usually not inherited. Most cases arise from gene changes that happen during life, especially extra copies or activity of the brachyury gene; rarely, inherited TBXT changes can raise spinal chordoma risk in families.
Having a genetic risk is not necessarily a diagnosis
Genetic variants are a usual part of human biology and are found commonly across the population. Most do not directly affect health and simply reflect the natural diversity seen among people. For many genes, having a variant associated with a condition points to a possible link, not a certain diagnosis, particularly when several genes and environmental influences play a role. In some situations, though, one well-studied variant in a particular gene is enough to confirm the diagnosis.
Pharmacogenetics—how genetics influence drug effects
For many living with spinal chordoma, treatment decisions often depend on whether surgery and radiation can fully control the tumor or whether more treatment is needed later. Doctors may test the tumor for genetic changes, because these changes can sometimes hint at how the cancer is behaving and whether a targeted medicine or clinical trial could help, especially if spinal chordoma returns or spreads. Not every difference in response is genetic, but test results can occasionally point to cell-growth signals that certain drugs are designed to block. This matters because there is no single standard drug plan that works for everyone, and medicines are often chosen case by case. Testing that predicts how your body breaks down a drug is not a routine part of spinal chordoma care today. Even so, the final treatment plan still depends on the full picture, including where the tumor is, whether it can be removed safely, side effects, and your overall health.
Interactions with other conditions
Spinal chordoma can affect more than the spine itself, especially when it presses on nearby nerves or the spinal cord and adds to problems someone may already have, such as chronic back pain, weakness, or trouble walking. This can make it harder to tell what is causing new symptoms, since spinal chordoma may overlap with more common conditions like a herniated disk, arthritis of the spine, or nerve damage from diabetes. Having more than one diagnosis can make symptoms feel harder to untangle. In some people, treatment for spinal chordoma, including surgery or radiation, may also interact with other health issues by increasing the need for careful planning around wound healing, infection risk, or bowel and bladder problems. If the tumor spreads, which can happen in advanced disease, lung or bone problems may develop and can complicate other illnesses that affect breathing, mobility, or pain control. Because the early symptoms of spinal chordoma can resemble everyday spine conditions, doctors usually look at the full picture so they do not miss another disease that needs treatment at the same time.
How genes can cause diseases
Humans have more than 20,000 genes, each carrying out one or a few specific functions in the body. One gene instructs the body to digest lactose from milk, another tells the body how to build strong bones and another prevents the body's cells from beginning to multiply uncontrollably and developing into cancer. As all of these genes combined are the building instructions for our body, a defect in one of these genes can have severe health consequences.
Through decades of genetic research, we know the genetic code of any healthy/functional human gene. We have also identified that in certain positions on a gene, some individuals may have a different genetic letter from the one you have. We call these hotspots "Genetic Variations" or "Variants" in short. In many cases, studies have been able to show that having the genetic letter "G" in the position makes you healthy, but having the letter "A" in the same position disrupts the gene function and causes a disease. Genopedia allows you to view these variants in genes and summarizes all that we know from scientific research, which genetic letters (Genotype) have good or bad consequences on your health or on your traits.
What other conditions can cause similar symptoms to Spinal chordoma?
Several more common problems can look like spinal chordoma at first, including a slipped disk, wear-and-tear changes in the spine such as arthritis, and narrowing in the spine that puts pressure on the nerves. Other spine tumors, including noncancerous growths and cancers that have spread to the spine from somewhere else in the body, can also cause very similar symptoms.
History
People living with spinal chordoma often spend a long time searching for answers before they ever hear the name of the condition. Because these tumors usually grow slowly and can start with common problems like back pain, neck pain, or pressure on nearby nerves, earlier generations were often diagnosed late, sometimes only after symptoms had been present for months or years.
Spinal chordoma entered medical writing in the 1800s, when doctors began linking certain unusual tumors of the spine and skull base to tissue left over from early development before birth. At first, these growths were mainly understood by what surgeons and pathologists could see during an operation or under a microscope. That meant the condition was often confused with other bone or soft tissue tumors, especially before modern imaging and lab testing became widely available.
As medical science evolved, doctors became better at separating spinal chordoma from look-alike cancers and from other causes of ongoing spine pain. Imaging tests such as CT and MRI changed the picture in a practical way. Instead of finding the tumor only during surgery, care teams could often see where it started, how far it had spread locally, and whether it was pressing on the spinal cord or nearby nerves. For many, this helped explain symptoms that had seemed vague at first, such as pain that keeps getting worse, numbness, or trouble with bladder or bowel control.
Treatment history has also changed steadily. In the past, surgery was often limited by how difficult these tumors are to reach safely, especially when they sit close to the spinal cord, major blood vessels, or the base of the skull. Over time, more specialized surgical approaches and more precise radiation techniques improved the chances of removing or controlling as much tumor as possible while protecting nearby tissue.
In recent decades, awareness has grown, and researchers have also learned more about the biology of spinal chordoma, including the fact that it has a genetic basis in some settings, though that part of the story belongs in its own discussion. Today, the history of spinal chordoma is not just about rare case reports. It is also about earlier recognition, more accurate diagnosis, and a clearer understanding that people with this condition often do best when care comes from teams with experience in complex spine and tumor treatment.